ZA907297B - Conjugate vaccine for group B streptococcus. - Google Patents

Conjugate vaccine for group B streptococcus.

Info

Publication number
ZA907297B
ZA907297B ZA907297A ZA907297A ZA907297B ZA 907297 B ZA907297 B ZA 907297B ZA 907297 A ZA907297 A ZA 907297A ZA 907297 A ZA907297 A ZA 907297A ZA 907297 B ZA907297 B ZA 907297B
Authority
ZA
South Africa
Prior art keywords
streptococcus
group
conjugate vaccine
vaccine
protein
Prior art date
Application number
ZA907297A
Other languages
English (en)
Inventor
James L Michel
Dennis L Kasper
Frederick M Ausubel
Original Assignee
Gen Hospital Corp
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp, Brigham & Womens Hospital filed Critical Gen Hospital Corp
Publication of ZA907297B publication Critical patent/ZA907297B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA907297A 1989-09-15 1990-09-13 Conjugate vaccine for group B streptococcus. ZA907297B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15

Publications (1)

Publication Number Publication Date
ZA907297B true ZA907297B (en) 1993-06-01

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907297A ZA907297B (en) 1989-09-15 1990-09-13 Conjugate vaccine for group B streptococcus.

Country Status (22)

Country Link
EP (1) EP0491865B1 (xx)
JP (2) JPH05500455A (xx)
KR (1) KR0180559B1 (xx)
AT (1) ATE146081T1 (xx)
AU (1) AU641439B2 (xx)
CA (2) CA2383393A1 (xx)
DE (1) DE69029396T2 (xx)
DK (1) DK0491865T3 (xx)
ES (1) ES2097154T3 (xx)
FI (1) FI105154B (xx)
GR (1) GR1002294B (xx)
HU (1) HU219327B (xx)
IE (1) IE903349A1 (xx)
IL (1) IL95578A (xx)
NO (1) NO313908B1 (xx)
NZ (1) NZ235316A (xx)
PL (3) PL167444B1 (xx)
PT (1) PT95316A (xx)
RU (1) RU2113234C1 (xx)
WO (1) WO1991004049A1 (xx)
YU (1) YU176490A (xx)
ZA (1) ZA907297B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
NZ248766A (en) * 1992-09-24 1996-11-26 Ca Nat Research Council Capsular polysaccharide-protein conjugate vaccine against group b streptococcus type ii or v
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
CN1046291C (zh) * 1993-03-19 1999-11-10 G·林达尔 Rib蛋白、其纯化方法、检测试剂盒及药物组合物
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
WO1999033969A1 (en) * 1997-12-31 1999-07-08 Pincus Seth H A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof in a vaccine
MX2007007033A (es) * 2004-12-22 2007-08-03 Novartis Vaccines & Diagnostic Estreptococus del grupo b.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
EP0302887B1 (en) * 1986-04-16 1994-06-22 The Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines, and methods of manufacture
WO1989000583A1 (en) * 1987-07-17 1989-01-26 Xoma Corporation Improved immunotoxin therapies utilizing purified ricin a-chain species

Also Published As

Publication number Publication date
PL286898A1 (en) 1991-06-03
NO920942D0 (no) 1992-03-11
AU641439B2 (en) 1993-09-23
IL95578A0 (en) 1991-06-30
FI105154B (fi) 2000-06-30
EP0491865A4 (en) 1993-05-05
IE903349A1 (en) 1991-04-10
IL95578A (en) 1998-08-16
PL167444B1 (pl) 1995-09-30
HUT63770A (en) 1993-10-28
NO313908B1 (no) 2002-12-23
KR920703097A (ko) 1992-12-17
JP3447713B2 (ja) 2003-09-16
ATE146081T1 (de) 1996-12-15
GR900100692A (el) 1992-01-20
PL167882B1 (pl) 1995-11-30
DE69029396D1 (de) 1997-01-23
ES2097154T3 (es) 1997-04-01
EP0491865B1 (en) 1996-12-11
AU6519090A (en) 1991-04-18
NO920942L (no) 1992-05-12
RU2113234C1 (ru) 1998-06-20
WO1991004049A1 (en) 1991-04-04
CA2066221C (en) 2002-07-23
EP0491865A1 (en) 1992-07-01
JP2001309795A (ja) 2001-11-06
FI921111A0 (fi) 1992-03-13
NZ235316A (en) 1992-11-25
KR0180559B1 (ko) 1999-03-20
PL168587B1 (pl) 1996-03-29
DE69029396T2 (de) 1997-06-05
JPH05500455A (ja) 1993-02-04
HU219327B (en) 2001-03-28
YU176490A (sh) 1992-12-21
PT95316A (pt) 1991-06-25
CA2066221A1 (en) 1991-03-16
CA2383393A1 (en) 1991-04-04
DK0491865T3 (da) 1997-06-02
GR1002294B (el) 1996-05-03

Similar Documents

Publication Publication Date Title
ZA907297B (en) Conjugate vaccine for group B streptococcus.
DE69002385D1 (de) Isolierung und strukturbestimmung des zytostatischen linearen depsipeptids dolastatin 15.
PL323822A1 (en) Polysaccharidic fragments of streotococcus type ii and type iii from antigenic group b processing terminal structure of 2,5-anhydro-d-mannose and conjugated cavvine made on their basis
EP0911036A3 (en) Dual carrier immunogenic construct
AU1130392A (en) Synthetic htlv-iii peptides, compositions and uses thereof
DK205585D0 (da) Polysaccharidproteinkonjugat, fremgangsmaade til fremstilling deraf ogpraeparat omfattende et polysaccharidproteinkonjugat
FI19991917A (fi) Parannettu meningokokki-polysakkaridikonjugaattirokote
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
BR9507400A (pt) Composições imunogénicas de polissacaridio streptococal grupo a e processos
ATE198834T1 (de) Konjugate bestehend aus polysaccharid und protein
WO1994010317A3 (en) Conjugate vaccine against group b streptococcus
ES2043900T3 (es) Conjugados de haptenos y proteinas y su utilizacion.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
WO1993020852A3 (en) Macrocyclic chelating agents, chelates and conjugates thereof